Page last updated: 2024-10-27

flecainide and Adenoma

flecainide has been researched along with Adenoma in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Adenoma: A benign epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
" Chronic administration of flecainide did not produce chronic toxic changes in either species."1.27Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice. ( Case, MT; Sibinski, LJ; Steffen, GR, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Case, MT1
Sibinski, LJ1
Steffen, GR1

Other Studies

1 other study available for flecainide and Adenoma

ArticleYear
Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice.
    Toxicology and applied pharmacology, 1984, Volume: 73, Issue:2

    Topics: Adenoma; Administration, Oral; Animals; Anti-Arrhythmia Agents; Body Weight; Carcinogens; Dose-Respo

1984